Xiaoling Zhang
Shanxi Medical University · 161 works · 6,606 citations · h-index 28
Top works
- Nivolumab plus Ipilimumab in Advanced Melanoma
- Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).
- Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer
- Late intellectual and academic outcomes following traumatic brain injury sustained during early childhood
- Programmed death-ligand 1 (PD-L1) expression in various tumor types
- Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies
- Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma
- Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer
- Sedation of mechanically ventilated adults in intensive care unit: a network meta-analysis
- Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis
- FOXA1 overexpression suppresses interferon signaling and immune response in cancer
- CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study
- Prognostic and predictive value of plasma d-dimer levels in patients with small-cell lung cancer
- Correlation Between Computed Tomography Features and Clinical Presentation and Management of Isolated Superior Mesenteric Artery Dissection
- Effect of acupuncture on inflammatory cytokines expression of spastic cerebral palsy rats
- Efficacy and Safety of 177Lu-DOTA-IBA in Tumor Bone Metastasis Treatment
- Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors >2 cm
- The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
- Undernutrition Shapes the Gut Microbiota and Bile Acid Profile in Association with Altered Gut-Liver FXR Signaling in Weaning Pigs
- PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report